Orally Disintegrating Tablet and Film Technologies - 5th Edition
Publication Date: March 2008
TCI's 5th Edition report on
Orally-Disintegrating Tablet and Film Technologies provides a comprehensive
overview of orally disintegrating delivery technologies (tablet and thin film systems). Also included in this report
are market analyses (current and forecasted), details on pipeline products, life cycle management drug candidates,
and business opportunities. The report specifically identifies orally disintegrating tablet (ODT) and oral thin
film (OTF) products currently available for co-development, co-marketing, and/or licensing. In total, more
than 90 companies are profiled in this report and represent a multitude of partnership opportunities for companies
active in the following segments:
- 35+ Orally Disintegrating Tablet Technologies
- 30+ Oral Thin Film Technologies
- 10 Excipient Technologies for ODT/OTF
- 19 Tastemasking Technologies
New to the Fifth Edition:
- Excipient technologies designed for disintegrating tablet/film preparations
- ANDA suitability petitions filed for oral thin films
- Erosion of US ODT brand sales by generics
- Expanded list of launched oral thin film products to include Asian formulators
- Alternative applications for thin film technologies including topical/transmucosal, veterinary, and consumer
- Updated drug candidates for ODTs based on lifecycle management
- Strategies for taste masking ODTs with nearly twenty technologies profiled
- Information on the first ODT vaccine
- Update on Paragraph IV lawsuits of generic ODTs
- Details on additional ODT and oral thin film technologies not covered in the fourth edition
